124 related articles for article (PubMed ID: 12621615)
1. Quantification of [Dmt1]DALDA in ovine plasma by on-line liquid chromatography/quadrupole time-of-flight mass spectrometry.
Wan H; Desiderio DM
Rapid Commun Mass Spectrom; 2003; 17(6):538-46. PubMed ID: 12621615
[TBL] [Abstract][Full Text] [Related]
2. Quantitative analysis of [Dmt(1)]DALDA in ovine plasma by capillary liquid chromatography-nanospray ion-trap mass spectrometry.
Wan H; Umstot ES; Szeto HH; Schiller PW; Desiderio DM
J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Apr; 803(1):83-90. PubMed ID: 15026001
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the binding of [3H][Dmt1]H-Dmt-D-Arg-Phe-Lys-NH2, a highly potent opioid peptide.
Neilan CL; Janvey AJ; Bolan E; Berezowska I; Nguyen TM; Schiller PW; Pasternak GW
J Pharmacol Exp Ther; 2003 Aug; 306(2):430-6. PubMed ID: 12663687
[TBL] [Abstract][Full Text] [Related]
4. Mass spectrometric quantification of the mu opioid receptor agonist Tyr-D-Arg-Phe-Lys-NH2 (DALDA) in high-performance liquid chromatography-purified ovine plasma.
Grigoriants OO; Tseng JL; Becklin RR; Desiderio DM
J Chromatogr B Biomed Sci Appl; 1997 Aug; 695(2):287-98. PubMed ID: 9300865
[TBL] [Abstract][Full Text] [Related]
5. In vivo pharmacokinetics of selective mu-opioid peptide agonists.
Szeto HH; Lovelace JL; Fridland G; Soong Y; Fasolo J; Wu D; Desiderio DM; Schiller PW
J Pharmacol Exp Ther; 2001 Jul; 298(1):57-61. PubMed ID: 11408525
[TBL] [Abstract][Full Text] [Related]
6. Comparison of [Dmt1]DALDA and DAMGO in binding and G protein activation at mu, delta, and kappa opioid receptors.
Zhao GM; Qian X; Schiller PW; Szeto HH
J Pharmacol Exp Ther; 2003 Dec; 307(3):947-54. PubMed ID: 14534366
[TBL] [Abstract][Full Text] [Related]
7. Dansylated analogues of the opioid peptide [Dmt1]DALDA: in vitro activity profiles and fluorescence parameters.
Berezowska I; Lemieux C; Chung NN; Zelent B; Schiller PW
Acta Biochim Pol; 2004; 51(1):107-13. PubMed ID: 15094830
[TBL] [Abstract][Full Text] [Related]
8. Type and location of fluorescent probes incorporated into the potent mu-opioid peptide [Dmt]DALDA affect potency, receptor selectivity and intrinsic efficacy.
Schiller PW; Berezowska I; Weltrowska G; Chen H; Lemieux C; Chung NN
J Pept Res; 2005 Jun; 65(6):556-63. PubMed ID: 15885115
[TBL] [Abstract][Full Text] [Related]
9. Antinociceptive and respiratory effects of intrathecal H-Tyr-D-Arg-Phe-Lys-NH2 (DALDA) and [Dmt1] DALDA.
Shimoyama M; Shimoyama N; Zhao GM; Schiller PW; Szeto HH
J Pharmacol Exp Ther; 2001 Apr; 297(1):364-71. PubMed ID: 11259564
[TBL] [Abstract][Full Text] [Related]
10. From the potent and selective mu opioid receptor agonist H-Dmt-d-Arg-Phe-Lys-NH(2) to the potent delta antagonist H-Dmt-Tic-Phe-Lys(Z)-OH.
Balboni G; Cocco MT; Salvadori S; Romagnoli R; Sasaki Y; Okada Y; Bryant SD; Jinsmaa Y; Lazarus LH
J Med Chem; 2005 Aug; 48(17):5608-11. PubMed ID: 16107162
[TBL] [Abstract][Full Text] [Related]
11. Matrix-assisted laser desorption/ionization mass spectrometric quantification of the mu opioid receptor agonist DAMGO in ovine plasma.
Desiderio DM; Wirth U; Lovelace JL; Fridland G; Umstot ES; Nguyen TM; Schiller PW; Szeto HS; Clapp JF
J Mass Spectrom; 2000 Jun; 35(6):725-33. PubMed ID: 10862125
[TBL] [Abstract][Full Text] [Related]
12. Tandem mass spectrometry analysis of synthetic opioid peptide analogs.
Tseng JL; Yan L; Fridland GH; Desiderio DM
Rapid Commun Mass Spectrom; 1995; 9(4):264-75. PubMed ID: 7756701
[TBL] [Abstract][Full Text] [Related]
13. Transcellular transport of a highly polar 3+ net charge opioid tetrapeptide.
Zhao K; Luo G; Zhao GM; Schiller PW; Szeto HH
J Pharmacol Exp Ther; 2003 Jan; 304(1):425-32. PubMed ID: 12490619
[TBL] [Abstract][Full Text] [Related]
14. Establishment of a liquid chromatographic/mass spectrometry method for quantification of tetrandrine in rat plasma and its application to pharmacokinetic study.
Song N; Zhang S; Li Q; Liu C
J Pharm Biomed Anal; 2008 Nov; 48(3):974-9. PubMed ID: 18650047
[TBL] [Abstract][Full Text] [Related]
15. Selective and sensitive liquid chromatography-tandem mass spectrometry method for the determination of levonorgestrel in human plasma.
Theron HB; Coetzee C; Sutherland FC; Wiesner JL; Swart KJ
J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Dec; 813(1-2):331-6. PubMed ID: 15556549
[TBL] [Abstract][Full Text] [Related]
16. Development of a high-performance liquid chromatography-tandem mass spectrometry method for the determination of flurogestone acetate in ovine plasma.
Monnoyer S; Capancioni S; Richard M; Pacaud M; Guyonnet J
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 May; 819(2):245-51. PubMed ID: 15833288
[TBL] [Abstract][Full Text] [Related]
17. In vivo disposition of dermorphin analog (DALDA) in nonpregnant and pregnant sheep.
Szeto HH; Clapp JF; Desiderio DM; Schiller PW; Grigoriants OO; Soong Y; Wu D; Olariu N; Tseng JL; Becklin R
J Pharmacol Exp Ther; 1998 Jan; 284(1):61-5. PubMed ID: 9435161
[TBL] [Abstract][Full Text] [Related]
18. Paclitaxel quantification in mouse plasma and tissues containing liposome-entrapped paclitaxel by liquid chromatography-tandem mass spectrometry: application to a pharmacokinetics study.
Guo W; Johnson JL; Khan S; Ahmad A; Ahmad I
Anal Biochem; 2005 Jan; 336(2):213-20. PubMed ID: 15620886
[TBL] [Abstract][Full Text] [Related]
19. Development of a liquid chromatography-tandem mass spectrometry method using capillary liquid chromatography and nanoelectrospray ionization-quadrupole time-of-flight hybrid mass spectrometer for the detection of milk allergens.
Weber D; Raymond P; Ben-Rejeb S; Lau B
J Agric Food Chem; 2006 Mar; 54(5):1604-10. PubMed ID: 16506808
[TBL] [Abstract][Full Text] [Related]
20. Development and evaluation of a candidate reference method for the determination of total cortisol in human serum using isotope dilution liquid chromatography/mass spectrometry and liquid chromatography/tandem mass spectrometry.
Tai SS; Welch MJ
Anal Chem; 2004 Feb; 76(4):1008-14. PubMed ID: 14961732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
